Physician profile
Kyle Woods
NPI 1104283464
$743.14
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $484 · 2022: $47.34 · 2023: $194 · 2024: $17.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $337.05 | 2021 | |
| Abbvie INC. | $67.61 | 2021-2023 | |
| Kyowa Kirin, INC. | $59.81 | 2023 | Nourianz |
| Lilly USA, LLC | $45.25 | 2023 | Reyvow, Emgality, Amyvid |
| Aurinia Pharma U.S., INC. | $42.71 | 2021 | |
| Opko Pharmaceuticals, LLC | $38.30 | 2021 | |
| Vifor Pharma, INC. | $31.36 | 2021 | |
| Pfizer INC. | $28.19 | 2023 | |
| Grifols USA, LLC | $24.86 | 2023 | Gamunex-C |
| Otsuka America Pharmaceutical, INC. | $22.06 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.93 | 2024 | Jardiance |
| Biogen, INC. | $14.98 | 2022 | |
| Glaxosmithkline, LLC. | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.